Sponsor or institution
Clinical trials and research at Banner Health
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Banner Health that are recruiting, at sites in 2 countries (most in United States (3), Colombia (1)). By phase: Phase 2/3 (1), Phase 2 (1). There are also 13 NIH-funded research projects at this institution, with $51.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 13NIH research projects
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Microwave Ablation Feasibility for pancreatic and liver cancers guided by endoscopic ultrasound | — | Gilbert, Arizona and 5 other locations | Recruiting | Sep 14, 2026 |
| Cytoreductive surgery plus heated intraperitoneal chemotherapy for gastric cancer with peritoneal-only spread | Phase 2 | Gilbert, Arizona | Recruiting | Sep 17, 2025 |
| Donanemab and RG6289 in PSEN1 E280A Mutation Carriers with autosomal-dominant Alzheimer’s disease | Phase 2/3 | Medellín, Antioquia | Recruiting | May 30, 2025 |
| A program to connect individuals interested in Alzheimer's prevention research | — | Phoenix, Arizona | Recruiting | Dec 30, 2013 |
All recruiting trials (4)
-
Microwave Ablation Feasibility for pancreatic and liver cancers guided by endoscopic ultrasound
This study tests whether an ultrasound-guided microwave ablation device can be safely and effectively used in adults with locally advanced, unresectable, or metastatic pancreatic or liver cancers.
-
Cytoreductive surgery plus heated intraperitoneal chemotherapy for gastric cancer with peritoneal-only spread
This study will try cytoreductive surgery combined with heated intraperitoneal chemotherapy, together with preoperative chemotherapy and laparoscopic HIPEC, in adults whose gastric adenocarcinoma is limited to the peritoneum or shows positive peritoneal cytology.
-
Donanemab and RG6289 in PSEN1 E280A Mutation Carriers with autosomal-dominant Alzheimer’s disease
Aimed at people with the PSEN1 E280A mutation, this study tests donanemab, RG6289, or both to see if the treatment can slow or alter disease progression.
-
A program to connect individuals interested in Alzheimer's prevention research
This study is for people who want to stay updated on Alzheimer's prevention research and learn about local studies they can join if they're interested.
NIH-funded research (13)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Alzheimer’s Prevention Initiative in Colombia ADAD trial
A study in Colombia aims to test ideas to prevent Alzheimer’s in people who carry a genetic mutation that almost guarantees they will develop the disease.
-
Alzheimer's Prevention Initiative ADAD Colombia Trial Program
A large NIH-funded effort is testing an approach to prevent Alzheimer's disease in people carrying a genetic mutation in Colombia.
-
Tracer harmonization for amyloid and tau PET imaging using statistics and deep learning
Aims to make PET brain scans for Alzheimer's disease more comparable across different tracers so doctors can better use the results for diagnosis and treatment decisions.
-
Preventing early-onset Alzheimer's in a large Colombian family with a PSEN1 mutation
This program tries treatments that remove amyloid to delay or prevent memory loss in people from a Colombian family who carry a PSEN1 mutation that causes early Alzheimer's.
-
Standardizing amyloid and tau PET brain scans
The team will create methods to make amyloid and tau PET brain scans more comparable so people being checked for Alzheimer’s get clearer, more consistent results.
-
Preventing Alzheimer's in a Colombian family with an inherited PSEN1 gene change
This project tests whether treatments that lower brain amyloid can delay or prevent Alzheimer's in people from a Colombian family who carry a genetic mutation that usually causes dementia in midlife.
-
Improving online Alzheimer's research registries to connect people with studies
This project builds better websites and tools to help older adults and their caregivers find and join Alzheimer's prevention and treatment research.
-
Investigating the role of APOE genes in Alzheimer's disease risk and prevention
This study is looking at how different versions of a gene called APOE might influence the chances of developing Alzheimer's disease in people aged 50 to 90 who are currently healthy, and it involves brain scans and blood tests to help researchers learn more about this connection over time.
-
Investigating a treatment to prevent Alzheimer's disease using a specific antibody.
This study is looking for older adults aged 65-80 who are at risk for Alzheimer's disease to see if a treatment called aducanumab can help prevent the disease by targeting certain proteins in the brain, and you'll either receive the treatment or a placebo over two years while we keep an eye on your thinking skills and
-
Comparing skin tests for diagnosing Lewy body dementia
This study is looking at how skin samples can help find a protein linked to Lewy body dementia, with the hope of making it easier and less invasive to diagnose this condition for people who have it.
-
Investigating ways to prevent Alzheimer's disease in families with a genetic risk.
This study is looking for people from a big Colombian family who have a genetic mutation that causes early Alzheimer's disease to see if new treatments can help prevent symptoms from starting, while also making sure everyone feels supported and involved throughout the process.
-
How cardiovascular genetics and APOE ε4 status affect amyloid levels in early Alzheimer's disease
This study is looking at how certain genes and the presence of the APOE ε4 gene might affect the buildup of amyloid plaques in people who are at risk for Alzheimer's disease, especially those with conditions like high cholesterol and high blood pressure, to see if there are ways to protect against Alzheimer's.
-
Improving brain imaging for Alzheimer's disease using advanced techniques
This study is working on improving brain scans for Alzheimer's disease by combining different imaging techniques to get clearer and more consistent results, which could lead to better diagnoses and treatments for patients.
Quick answers
How many clinical trials run by Banner Health are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Colombia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.